AMITRIPTYLINE GxP amitriptyline hydrochloride 50 mg tablets blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

amitriptyline hydrochloride, Quantity: 50 mg

Disponible depuis:

Arrotex Pharmaceuticals Pty Ltd

DCI (Dénomination commune internationale):

amitriptyline hydrochloride

forme pharmaceutique:

Tablet

Composition:

Excipient Ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350

Mode d'administration:

Oral

Unités en paquet:

50's, 100's, 10's, 1000's

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

For the treatment of major depression. AMITRIPTYLINE GxP 50mg tablets are indicated only for the maintenance treatment of major depression (see Precautions). Nocturnal enuresis where organic pathology has been excluded.

Descriptif du produit:

Visual Identification: Round brown coloured biconvex tablets debossed AM on one side and 50 on other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2015-11-27